Imugene

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing HER2 + ve gastric and breast cancer vaccines. The Group's lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.

Contact Details

37 Bligh Street , Suite 1006, Level 10 SYDNEY NSW 2000
www.imugene.com

Lists and Charts

Share price

Imugene
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
1657th /Company/Euro-Manganese -64.81% -23.24%
1658th /Company/Security-Matters -64.99% 0%
1659th /Company/Imugene -65% -6.89%
1660th /Company/Arizona-Lithium -65% 14.87%
1661st /Company/Pantera-Minerals -65.01% 0%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

01/07/24
Issued
Imugene
01/07/24
Other
Imugene
01/07/24
Other
Imugene
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: Bradley Glover, 04 Oct 2024
NEW ROLE: Paul Woodard, 04 Oct 2024
NEW ROLE: Kim Drapkin, Non-Executive Director 31 Jul 2024
NEWS: Tagged in Cancer-fighting mission shoots Imugene up ASX boards 13 Nov 2023
NEW ROLE: Giovanni Selvaggi, 30 Oct 2023
NEW ROLE: Jakob Dupoint, 30 Oct 2023
NEWS: Tagged in Healthtech banks on rising numbers 07 Nov 2022
NEW ROLE: Monil Shah, 23 Sep 2022
NEWS: Tagged in Where markets meet medicine; a biotech entrepreneur at the tip of the spear 14 Feb 2022

News Articles

Related Information

Access to our data for Imugene is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Imugene is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today

X